Theseus Pharmaceuticals Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-15,734	-16,661	-10,645	5,057	6.53	-10.56
Depreciation & Amortization	2,099	2,372	1,728	841.77	553.07	143.65
Other Amortization	-	-	-	-	35.9	13.18
Other Operating Activities	9,377	9,022	-28,003	-4,827	4,245	-4,563
Operating Cash Flow	-4,259	-5,267	-36,920	1,071	4,840	-4,417
Operating Cash Flow Growth	-	-	-	-77.87%	-	-
Capital Expenditures	-241.36	-259.59	-14,117	-1,647	-350.34	-13.08
Sale of Property, Plant & Equipment	40.01	40.01	30	-	-	-
Cash Acquisitions	-	-	-	-5,034	-3,250	-1,750
Sale (Purchase) of Intangibles	-	-	-3,683	-16.84	-52.5	-84.02
Investment in Securities	1,247	-	-10,263	-5,371	-12,697	-13,558
Other Investing Activities	3,281	3,709	1,288	15,991	-2,966	-15,906
Investing Cash Flow	3,387	2,550	-24,745	3,923	-19,316	-31,311
Short-Term Debt Issued	-	226.91	143.3	166.1	12,860	3,899
Total Debt Issued	26.91	226.91	143.3	166.1	12,860	3,899
Short-Term Debt Repaid	-	-	-	-13,311	-3,629	-
Long-Term Debt Repaid	-	-378.19	-711.24	-534.82	-325	-
Total Debt Repaid	-378.19	-378.19	-711.24	-13,846	-3,954	-
Net Debt Issued (Repaid)	-351.28	-151.28	-567.93	-13,680	8,906	3,899
Issuance of Common Stock	0.82	1.63	57,000	15,891	-	35,130
Financing Cash Flow	-350.46	-149.65	56,432	2,211	8,906	39,029
Net Cash Flow	-1,222	-2,867	-5,233	7,204	-5,570	3,301
Free Cash Flow	-4,500	-5,526	-51,038	-575.4	4,490	-4,430
Free Cash Flow Margin	-22.56%	-28.55%	-205.72%	-1.43%	18.87%	-68.58%
Free Cash Flow Per Share	-1.14	-1.40	-14.85	-0.20	1.84	-1.82
Cash Interest Paid	434.06	434.06	176.02	96.13	-	-
Cash Income Tax Paid	-	-	182.38	112.69	-	-
Levered Free Cash Flow	3,012	2,781	-40,327	-14,119	4,299	-
Unlevered Free Cash Flow	3,301	3,052	-40,217	-14,059	4,314	-
Change in Net Working Capital	-18,340	-18,908	12,750	14,175	-4,801	-

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.